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Background: In epidemiological studies of asthma, questionnaires to differentiate asthmatics from non-asthmatics
have proven to be cost-effective and convenient. The aim of this study was to analyze the association between
hyperresponsiveness to methacholine and the validity of five items for the asthma like questionnaire recommended
by the Global Initiative for Asthma (GINA).
Methods: A total of 680 subjects who visited the pulmonology department with suspected symptoms of asthma
were enrolled. All participants completed five items questionnaires and underwent methacholine bronchial
provocation tests (MBPT). The diagnostic value of the questionnaire was assessed through analysis of the sensitivity,
specificity, and positive and negative predictive values.
Results: Multivariate logistic regression analysis showed that questionnaires about wheezing, exercise induced
dyspnea and pollution-induced dyspnea were useful for differentiating asthmatics from non-asthmatics (adjusted
odds ratio (OR) =2.0, 95% confidence interval (CI) 1.3-3.0; OR =2.3, 95% CI 1.5-3.5; OR =2.0, 95% CI 1.3-3.0)
respectively. A total symptom score of higher than 1 was associated with the highest sensitivity (98.4%) and
lowest specificity (9.4%). In contrast, a total symptom score of more than 5 was associated with the highest
specificity (91.9%) and lowest sensitivity (18.5%)
Conclusions: Although questionnaires are not a sufficiently accurate method for diagnosing asthma, properly
selected questionnaire can be used as effective strategies in situations such as private clinics or large population
based epidemiologic studies.
Keywords: Questionnaire, Bronchial hyper responsiveness, Asthma like symptomsBackground
The prevalence of asthma has increased continuously
worldwide in recent decades [1]. Asthma is clinically diag-
nosed by physicians with asthma like symptoms of patients
in community settings. However, asthma incidence cannot
be determined precisely because there is no generally ac-
cepted gold standard definition of asthma. The Medical Re-
search Council (MRC) developed a questionnaire to detect* Correspondence: cem@ewha.ac.kr
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unless otherwise stated.chronic bronchitis; a similar questionnaire was designed for
asthma several years later [2]. Thereafter, large population-
based epidemiological studies of asthma have usually relied
on several types of questionnaires of symptom-based
components, such as wheezing or tightness of the chest
[3]. To increase the accuracy of epidemiological surveys
of asthma, objective measurements of airway hyperre-
sponsiveness have been used as supplements for diag-
nosing asthma [4]. International guidelines recommend
that asthma should be suspected in patients with re-
spiratory symptoms such as chronic cough, wheezing
episodes, dyspnea, chest tightness and a positive bron-
chial hyperresponsiveness (BHR) [5]. Until recently,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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of symptom-based questionnaires to distinguish asth-
matics from non-asthmatics due to their convenience
and cost-effectiveness [6,7]. Therefore, most studies of
the prevalence of asthma have used patient question-
naires inquiring about episodes of wheezing, dyspnea,
and persistent cough [8]. However, this approach often
fails to detect asthma accurately because most studies
inquire about subjective symptoms; e.g., physicians and
patients may interpret the term “wheeze” differently.
Questionnaires alone can misjudge the prevalence of
asthma due to the lack of a standard definition. Thus,
epidemiological surveys that collect data using ques-
tionnaires often overestimate asthma prevalence [9]. In
contrast, many patients with true asthma are diagnosed
as non-asthmatics or are misdiagnosed with other
respiratory illnesses. The most common characteristic
of asthma is the hyperresponsiveness of the airway
to the stimuli which generally cannot influence non-
asthmatics. Previous studies have demonstrated that
asthmatics are more likely to have BHR than non-
asthmatics. In contrary, some studies reported that the
presence of BHR cannot accurately discriminate asth-
matics from non-asthmatics in population based studies
[10]. Although BHR is not considered essential factor to
diagnosis asthma due to low sensitivity, it is most avail-
able method to assess the validity of asthma diagnosed
by questionnaires. Therefore, BHR is widely recognized
as the standard diagnostic parameter for asthma in spite
of clinical inaccuracy. Asthma might be diagnosed when
there are both positive asthma symptoms and BHR [11].
The methacholine provocation test (MBPT) has been
used universally to assess BHR in patients with asthma.
The MBPT can be repeated easily and correlates rela-
tively well with the presence and clinical severity of
asthma [12]. Although MBPT is regarded as a standard
method to confirm the presence of BHR, it has limitations
precluding its use as the definitive tool for diagnosis of
asthma. Although there is a predictable relationship be-
tween a positive BHR and asthma, BHR is not a highly
sensitive or specific strategy for the clinical diagnosis of
asthma [13]. Unfortunately, a negative response to the
methacholine test does not completely exclude asthma. In
addition, MBPT is also costly and time consuming to
perform in epidemiological studies or in private clinics. To
enhance the accuracy of questionnaires, scoring systems
to identify asthma in large population surveys using a
combination of predictor variables collected by question-
naires have been developed [14,15]. Therefore, the present
study was designed to validate the accuracy of five ques-
tions representing asthma like symptoms along with
the MBPT, and to evaluate the clinical usefulness of
this method in private clinics or large-population-based
epidemiological surveys.Methods
Participants and study design
Six hundred and eighty subjects were recruited from pa-
tients visited to the outpatient department with varied
respiratory symptoms suggesting asthma, such as dys-
pnea, chronic cough, chest tightness and wheezing. Par-
ticipants were mixed populations referred from other
primary physicians and visited to pulmonary department
by themselves without consultations. At the first visit,
all subjects were asked to complete five asthma screen-
ing questionnaires developed based on common ques-
tions recommended by GINA guidelines regarding
respiratory symptoms associated with asthma [16]. The
answers to each question were recorded simultaneously
and all questions could be answered with “yes” or “no”.
The total symptom score was calculated by summing
the scores corresponding to each question. Participants
were divided into two groups of asthmatics and non-
asthmatics. Participants were classified as asthmatics if
the subjects were matched to the following criteria: 20%
decrease in forced expiratory volume in 1 second (FEV1)
with a dose of <16 mg/mL inhaled methacholine. Partic-
ipants with negative results on the methacholine chal-
lenge test were regarded as non-asthmatics. Exclusion
criteria were as follows: 1) current diagnosis of pneumo-
nia, emphysema, tuberculosis or other lower respiratory
tract diseases, and infections of the ear, sinus, or upper
respiratory tract diseases, 2) uncontrolled cardiovascular
diseases, malignancy, immunosuppressive diseases, 3)
patients hospitalized within 3 months due to other re-
spiratory diseases; 4) pregnant and breastfeeding women,
and patients under 18 years old. The subjects having
other lung diseases including pneumonia, emphysema,
tuberculosis, interstitial lung disease were exclude by
radiologic examinations.
Procedures
Subjects who met the eligibility criteria for this study re-
ceived informations about the protocols. Each participant
who met the criteria answered the five questions, receiving
help from nurses or physicians. All participants underwent
basal spirometry (Sensor Medics, Yorba Linda, CA. USA).
The following parameters were measured: FEV1, FVC, and
FEV1/FVC. The highest FEV1 was selected among three
consecutive procedures with basal spirometry. Subjects
with a basal FEV1 of more than 70% of the predictive value
by spirometry underwent MBPTs. Prior to the MBPT, sub-
jects were asked to discontinue any medications that could
interfere with the methacholine test. The diagnosis of
asthma was confirmed based on a positive response to the
MBPT (PC20 ≤ 16 mg/dL of inhaled methacholine). The
incremental concentrations of methacholine chloride pre-
pared from the dosing protocol were 0.0625, 0.25, 1, 4, 16,
25, and 50 mg/mL. A decrease of ≥20% of the baseline
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sidered a positive response. Methacholine was inhaled
using the 2-min tidal breathing method with a synchro-
nized nebulizer or five-breath dosimeter method (DSM-2)
according to ATS guidelines. Spirometry was repeated
3 min after each increased dose of methacholine. After the
methacholine test, all participants received salbutamol and
repeated spirometry was performed to assess recovery of
lung function. Patients were divided into two groups, asth-
matics and non-asthmatics, according to the results of the
MBPT. Patients were diagnosed with asthma if their an-
swers to the questionnaire suggested it and the MBPT was
positive. The relationship between asthma symptoms and
the presence of BHR was determined by the sensitivity
(proportion of patients with BHR who had a positive ques-
tionnaire result) and specificity (proportion of patients
with normal responsiveness who had a negative question-
naire result). The baseline characteristics of the asthmatics
and non-asthmatics are shown in Table 1. This study
protocol was approved by the Institutional Review Board
(Approval No. ECT198-2-16) of Ewha Womans University
Mokdong Hospital and we received written informed con-
sent from participants.
Asthma screening five-item questionnaire based on GINA
Q1. Has the patient had an attack of wheezing?
Q2. Does the patient have wheeze or dyspnea after
exercise?
Q3. Does the patient have a troublesome cough at night?
Q4. Did the patient’s cold take more than 10 days to
clear up?
Q5. Did the patient experience wheezing, chest
tightness, or cough after exposure to airborne
allergens or pollutants?Table 1 Baseline characteristics of subjects who
underwent MBPT and completed questionnaire
Characteristic Asthmatics Non-asthmatics
(n = 164) (n = 516)
Mean age, years 43 (20–64) 49 (20–81)
Gender (male: female) 2:3 2:3
Body mass index, kg/m2† 23.5 ± 2.4 (17–30) 22.6 ± 2.4 (17–30)
Smoking history, number (%)
Never smoked 96 (58) 296 (57)
Current smoker 22 (13) 120 (23)
Ex-smoker 2 (1) 42 (8)
FEV1 (%predicted) 93 (70–135) 98 (70–148)
FEV1/FVC (%predicted) 78 (70–95) 82 (70–99)
†P <0.05; compared with non-asthmatic patients by MBPT.
Abbreviations: MBPT methacholine bronchial provocation test, FEV1 forced
expiratory volume in 1 second, FEV1/ FVC forced expiratory volume in
1 second/forced vital capacity.Statistical analysis
The mean total symptom scores for the two groups were
compared using Student’s t-test. Multivariate logistic re-
gression analysis was performed to determine whether
the five questions used as independent variables could
significantly differentiate asthmatics and non-asthmatics.
The correlation between the questionnaire and asthma
was defined by the odds ratios (OR) and 95% confidence
intervals (CI). A receiver-operating characteristic (ROC)
curve analysis was performed to assess the diagnostic ac-
curacy of the symptom-assisted diagnosis. A p value less
than 0.05 was considered to indicate statistical signifi-
cance. Statistical analyses were performed using SPSS
version 16.0 (SPSS, INC, Chicago, IL, USA).
Results
Of the 680 subjects, 24% (n = 164) had asthma and 76%
(n = 516) did not. Differences in the baseline clinical
characteristics of asthmatics and non-asthmatics were
not statistically significant, with the exception of the
body mass index (BMI) (Table 1). The BMI of the asth-
matics was higher than that of the non-asthmatics
(mean 23.5 ± 2.4 vs. 22.6 ± 2.4, p <0.05). Table 2 shows
the prevalence and predictive value of each question for
diagnosing asthma. The exercise-induced dyspnea ques-
tion had the highest sensitivity (70.2%) but a relatively
low specificity (49.1%). By contrast, attacks of wheezing
had the highest specificity (65.8%), but moderate sensi-
tivity (50.8%). Five questionnaires showed high negative
predictive values (NPV) of over 82% but low positive
predictive values (PPV) of less than 28%. Table 3 shows
the multivariate logistic regression analysis of the associ-
ation between the questionnaire and the results of the
MBPT. Exercise-induced dyspnea was the most signifi-
cant questionnaire item that differentiated asthma pa-
tients from non-asthmatic patients (OR = 2.3, CI: 1.5 to
3.5, p <0.001). Recurrent attacks of wheezing and aller-
gen or pollution induced dyspnea were also highly corre-
lated with the diagnosis of asthma after adjusting for all
symptoms (OR = 2.0, CI: 1.3 to 3.0, p <0.001). With an
increase of the cutoff value from 1 to 5, the sensitivity
decreased progressively (from 98.4% to 18.5%), while the
specificity increased continuously (from 9.4% to 91.9%).
A total symptom score of ≥3 was associated with moder-
ate sensitivity (68.5%) and specificity (48%) (Table 4).
Table 5 shows that a PC20 ≤ 50 mg/ml (62.4%) exhibited
a slightly higher sensitivity than did a PC20 ≤ 25 mg/ml
(44.2%); however, the predictability of PPV was similar
for both methacholine doses. The diagnostic value of
the questionnaire was evaluated by ROC analysis. The
AUC of the ROC curve was 0.610 ± 0.029 (Figure 1). An
AUC OF 0.6 appears that BHR in this cohort means
modestly predictive of an increased symptom score for
the asthma group.
Table 2 Prevalence and predictive values of questions for diagnosing asthma by GINA
Question Prevalence (%) Sensitivity (%) Specificity (%) PPV* (%) NPV† (%)
Q1. Wheezing 38 50.8 65.8 28.1 83.6
Q2. Exercise-induced dyspnea 53 70.2 49.1 26.7 86.2
Q3. Nocturnal cough/dyspnea 47 62.1 44.8 22.8 81.8
Q4. URI‡ ≥10 days 49 64.5 42.2 22.7 81.8
Q5. Pollution-induced dyspnea 50 66.1 39.7 22.4 81.7
Abbreviations: *PPV positive predictive value, †NPV negative predictive value. ‡URI upper respiratory tract infection.
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The acceptable method to identify asthma patients seems
to be a combination of asthma like symptoms and bron-
chial challenge test, in addition to a clinical diagnosis by a
physician [17]. BHR is considered as a relatively standard
diagnostic method for asthma but has several limitations.
First, many subjects with BHR were asymptomatic; BHR
has high sensitivity but low specificity as a diagnostic tool
for asthma. MBPT frequently underestimates the sensitiv-
ity of the asthma questionnaire [18]. Second, MBPT is a
costly and time-consuming method for use in a large
population-based epidemiology survey. Therefore, the con-
ventional questionnaire for detecting asthma has been
used widely in epidemiological surveys due to its cost-
effectiveness and convenience. However, there has not
been developed a generally accepted questionnaire for
diagnosing asthma until now. We attempted to overcome
this limitation using a questionnaire that was properly cor-
related with the clinical symptoms of asthma. Although
there have been a few reports concerning the validity of
the respiratory questionnaire for detection of asthma, this
paper is the first to validate the asthma questionnaire rec-
ommended by GINA in combination with the MBPT re-
sults of adult respiratory patients in Korea. Although
obesity has been known to evoke or aggravate asthma
in the general population, deteriorating airway hyper-
responsiveness is not thought to do so [19-22]. In ourTable 3 Multivariate logistic regression analysis of
questions by GINA





Q1. Wheezing 63 161 2.0 (1.3-3.0) <0.001
Q2. Exercise-induced
dyspnea
87 239 2.3 (1.5-3.5) <0.001
Q3. Nocturnal cough
or dyspnea
77 260 1.3 (0.9-2.0) 0.169
Q4. URI ≥10 days 80 273 1.3 (0.9-2.0) 0.187
Q5. Pollution-induced
dyspnea
63 161 2.0 (1.3-3.0) <0.001
Abbreviations: *OR odds ratio, †CI, confidence interval.study, the baseline characteristics of both groups were not
statistically significantly different, with the exception of
body mass index (BMI). Present study also demonstrated
that obesity certainly play a role to increase the incidence
of asthma. To validate the questionnaire, one must calcu-
late the sensitivity and specificity. Sensitivity is the propor-
tion of subjects truly diseased based on the questionnaire;
specificity is the proportion of subjects to be healthy based
on the questionnaire. Kilpelainen et al. reported the valid-
ation of a questionnaire for respiratory symptoms in pa-
tients with “current asthma”; wheezing with episodes of
shortness of breath showed a high specificity (93%) and a
moderate -to-low sensitivity (45%) [23]. In our study,
wheezing showed a sensitivity of 50.8% and a specificity of
65.8%. Exercise-induced dyspnea had a sensitivity of 70.2%
and a specificity of 49.1%. The possible causes of the com-
paratively low sensitivity of wheezing in our study are that
wheezing is interpreted subjectively by patients and wheez-
ing in asthma patients is sometimes underestimated due
to confusion with other diseases producing wheezing, such
as COPD and localized obstructive bronchial diseases (e.g.
cancer, endobronchial lesions, etc.). Additionally, the
underestimated effect of MBPT when combined with a
questionnaire is a probably negative factor for the sensitiv-
ity of asthma. The other possible reason for the low sensi-
tivity of wheezing is that it is determined usually by
physicians rather than patients, and many asthma patients
report no asthma symptoms despite a positive BHR.
Jenkins et al. reported that questionnaires are valid instru-
ments for the determination of asthma symptoms in the
previous 12 months [24]. They reported that self -reported
symptoms had a higher Youden’s Index than did BHRTable 4 Sensitivity and specificity of combined scores of
each symptom for diagnosis of asthma by GINA






Table 5 Prediction of asthma using PC20 values of
≤25 mg/ml and ≤50 mg/ml
Sensitivity Specificity PPV* NPV†
44.2 75.2 88.5 24.0
62.4 52.2 84.8 24.7
Abbreviations: *PPV positive predictive value, †NPV negative predictive value.
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index, (J) =maximum {sensitivity( c ) + specificity( c )-1}, is
generally used as the method of overall diagnostic effect-
iveness. The value close to 1 indicate that the biomarker’s
effectiveness is relatively large [25]. Symptoms combined
with the BHR showed increased specificity with a severely
decreased sensitivity due to inclusion of the BHR. In gen-
eral, many other population-based studies showed similar
results to those of Jenkins et al. with a specificity of more
than 90%, a sensitivity of 20-50%, and a Youden’s Index of
less than ~40% [26-28]. They suggested that physician
diagnosis of asthma used by questionnaire appears reason-
able tool because diagnosis of BHR plus questionnaire usu-
ally decrease the incidence of asthma due to low sensitivity
of BHR. The purpose of epidemiological studies of
the prevalence of asthma is to assess the risks associated
with the various factors that evoke asthma. Therefore,
questionnaires with high specificity and low sensitivity are
more useful measures rather than with a lower specificity
and high sensitivity. To the contrary, Smeeton et al. re-
ported that the low coincidence between the standardizedFigure 1 Area under the receive operating curve (ROC) for the sympt
probability of higher symptom scores for asthma group was 61% greater thquestionnaire and the postdemonstration questionnaire of
asthma decreases the usefulness of this method for asses-
sing the prevalence of asthma. The prevalence following
the demonstration were 30–60 percent lower than those
from the standardized questionnaire [29]. If we considered
the prevalence of postdemonstration questionnaire as ap-
propriate numbers of asthma, the prevalence of asthma re-
ported by standardized questionnaires may be decrease. Of
the questions, three items—attacks of wheezing, exercise-
induced dyspnea, and allergen-induced dyspnea—were
relatively well correlated with the presence of asthma. The
high correlation with asthma symptoms suggests that
those questions are closely related to the pathophysiology,
which involves inflammation of pulmonary airways and
bronchial hyper-responsiveness [30]. Our selective ques-
tionnaire had a relatively high negative predictive value
(NPV) of over 82% despite a very low positive predictive
value (PPV). This high NPV is a better asthma indicator
for use in epidemiological studies. The items that differen-
tiated asthmatics from non-asthmatics after multivariate
logistic regression were exercise-induced dyspnea, recur-
rent attacks of wheezing, and pollution induced dyspnea
(OR = 2.3, CI 1.5 to 3.5; OR = 2.0, CI 1.3 to 3.0; OR = 2.0,
CI 1.3 to 3.0) respectively. On the contrary, questions
about nocturnal cough or dyspnea and upper respiratory
symptoms of more than 10 days’ duration were not able to
discriminate between asthma and other respiratory condi-
tions because these symptoms may be frequently followed
by upper or lower respiratory infections and therefore haveom score. The AUC of the ROC curve was 0.610 ± 0.029. The
an for the control group.
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from non-asthmatics. Shin et al. reported that a cutoff
point of the total symptom score equal to or greater than
the four questions was associated with the highest sensitiv-
ity (96%) and specificity (100%) [31]. However, their study
involved fewer than 50 subjects, possibly introducing
population bias. They also demonstrated that with an in-
creased cutoff, the sensitivity decreased continuously,
while the specificity remained ~100%. However, our study
showed somewhat different results for a total score of ≥2,
which had a sensitivity of 86.3% and a specificity of 20.4%.
However, as the cutoff point increased, sensitivity de-
creased continuously from 98.4% to 18.5%, while specificity
increased from 9.4% to 91.9%. In epidemiological surveys,
a high specificity results in more effective detection of
asthma and a high cutoff is more favorable for differenti-
ation of asthmatics from non-asthmatics. Kim et al. re-
ported the prevalence of childhood asthma based on
questionnaires regarding asthmatic symptoms in Korea,
and demonstrated that the sensitivity and specificity of
wheezing, exercise induced dyspnea, and nocturnal dys-
pnea were 56.3%, 41.8%, and 37.9% vs. 69.0%, 41%, and
79%, respectively [32]. In the present study on adult
asthma, the sensitivity and specificity of wheezing were
similar to those in childhood asthma; however, the sensi-
tivity of exercise-induced dyspnea in adult asthma was
higher than that in childhood asthma, 41.8% vs. 70.2%, re-
spectively. Therefore, exercise-induced symptoms may be
more useful for diagnosis of adult than childhood asthma.
In present study, exercise-induced dyspnea showed highest
sensitivity (70.2%) and PPV (86.2%) among questions and
this item is strongly recommended for diagnosing adult
asthma. Zhong et al. reported that ~45% of asymptomatic
students with a positive BHR developed asthma in the fol-
lowing 2 years [33]. In present study, a PC20 ≤ 50 mg/ml
exhibited a higher sensitivity than a PC20 ≤ 25 mg/ml. The
PC20 ≤ 50 mg/ml value is better at detecting mild asthma,
particularly in cases of frequent or prolonged mild respira-
tory symptoms, such as chronic cough, which is frequently
regarded as a symptom of simple upper respiratory infec-
tions in a clinical setting. The result of negative MBPT
does not always exclude clinical asthma because the results
of MBPT vary according to the purity of methacholine and
the protocols. Therefore, in cases of patients with a nega-
tive MBPT and significant respiratory symptoms related to
asthma, patients should be followed up and probably need
to repeat MBPT at other times. On the other hand, sub-
jects with a positive MBPT and no asthma symptoms must
also be followed up because some subjects will likely be
confirmed to be asthmatics within several years. Therefore,
the asymptomatic subject with a positive BHR must be
followed carefully to detect asthma early on. Early diagno-
sis of asthma may be very helpful to prevent asthma pa-
tients from progressing to permanent airway remodelingwhich can no longer be controlled by conventional asthma
treatments. The questionnaire used in the present study
may be suggested that it is a relatively convenient, accurate
and cost-effective strategy for differentiating asthmatics
from non-asthmatics. However, our study had several limi-
tations. First, one major limitation is that there was no
healthy control group. This problem probably make it
somewhat difficult to argue that it is possible to calculate
sensitivity and specificity of a symptom questionnaire to
detect specific disease. Second, present study was per-
formed at only one university hospital placed in a large
city with relatively severe air pollution and a high dens-
ity of population. Several environmental factors, such
as economic state, the situation of air pollution, and the
age of subjects, might have influenced our results.
Third, this study included relatively small numbers of
patients for an epidemiological survey. Despite its weak-
nesses, the major strength of this study is that elucidate
the clinical validity of a selectively chosen questions recom-
mended by GINA for diagnosing asthma in the general
adult population. Especially, among five items, exercise-
induced dyspnea, recurrent attacks of wheezing, and pollu-
tion induced dyspnea are more useful to differentiate asth-
matics from non-asthmatics. Therefore, these three items
may be adjusted to diagnose asthma more frequently than
other questions.
Conclusions
Present study showed that questionnaire which is prop-
erly matched with asthma like symptoms may be useful
acceptable screening method to diagnosis asthma when
MBPT is not available such as private clinics and epi-
demiological studies. A randomized large-scale study is
needed to confirm our findings and the clinical useful-
ness of our methods in a private clinic or epidemio-
logical survey.
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